Loading...
OptimizeRx Corporation
OPRX•NASDAQ
Healthcare
Medical - Healthcare Information Services
$14.35
$0.41(2.94%)
OptimizeRx Corporation (OPRX) Financial Performance & Income Statement Overview
Review OptimizeRx Corporation’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
28.81%
↑ 28.81%
Operating Income Growth
48.09%
↑ 48.09%
Net Income Growth
-14.48%
↓ 14.48%
Operating Cash Flow Growth
167.54%
↑ 167.54%
Operating Margin
-11.44%
↓ 11.44%
Gross Margin
62.97%
↑ 62.97%
Net Profit Margin
-16.33%
↓ 16.33%
ROE
-13.15%
↓ 13.15%
ROIC
-7.22%
↓ 7.22%
OptimizeRx Corporation (OPRX) Income Statement & Financial Overview
Review OptimizeRx Corporation's (OPRX) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $32.32M | $21.31M | $18.81M | $19.69M |
| Cost of Revenue | $10.29M | $7.86M | $7.11M | $8.55M |
| Gross Profit | $22.02M | $13.45M | $11.70M | $11.14M |
| Gross Profit Ratio | $0.68 | $0.63 | $0.62 | $0.57 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $71000.00 |
| SG&A Expenses | $17.30M | $13.43M | $14.38M | $16.17M |
| Operating Expenses | $18.39M | $22.009M | $14.38M | $16.17M |
| Total Costs & Expenses | $24.65M | $29.87M | $22.56M | $24.72M |
| Interest Income | $98000.00 | $107000.00 | $106000.00 | $20000.00 |
| Interest Expense | $1.56M | $1.52M | $1.53M | $1.55M |
| Depreciation & Amortization | $1.09M | $1.09M | $1.07M | $1.07M |
| EBITDA | $4.87M | -$7.32M | -$2.50M | -$3.94M |
| EBITDA Ratio | $0.15 | -$0.34 | -$0.13 | -$0.20 |
| Operating Income | $3.63M | -$8.56M | -$3.75M | -$5.03M |
| Operating Income Ratio | $0.11 | -$0.40 | -$0.20 | -$0.26 |
| Other Income/Expenses (Net) | -$1.43M | -$1.38M | -$1.35M | -$1.53M |
| Income Before Tax | $2.21M | -$9.94M | -$5.10M | -$6.55M |
| Income Before Tax Ratio | $0.07 | -$0.47 | -$0.27 | -$0.33 |
| Income Tax Expense | $2.29M | -$817000.00 | -$1.09M | $344000.00 |
| Net Income | -$77000.00 | -$9.12M | -$4.008M | -$6.90M |
| Net Income Ratio | -$0.002 | -$0.43 | -$0.21 | -$0.35 |
| EPS | -$0.004 | -$0.50 | -$0.22 | -$0.38 |
| Diluted EPS | -$0.004 | -$0.50 | -$0.22 | -$0.38 |
| Weighted Avg Shares Outstanding | $18.42M | $18.32M | $18.26M | $18.17M |
| Weighted Avg Shares Outstanding (Diluted) | $18.42M | $18.32M | $18.26M | $18.17M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan